LymeX Authorization Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, LymeX Authorization Act, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Education, Finance.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section HC1DF5F0D1BD34A65A746C5D1559BBD3C: 1. Short title This Act may be cited as the LymeX Authorization Act.
- Section HE9D7038A548B48C98CB708CD0BB29ED3: 2. Policy It is the policy of the United States to— engage stakeholders, including academia, nonprofits, industry, small business, entrepreneurs, and...
- Section H326009E6940540DD9A54E9A9213BD4EF: 3. Authorization of appropriations There is authorized to be appropriated to the Secretary of Health and Human Services $5,000,000 to carry out prize...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, LymeX Authorization Act, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Education, Finance
Primary Purpose
This bill, LymeX Authorization Act, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
In CommitteeReferred to the House Committee on Energy and Commerce.
Introduced in House
Mr. Smith of New Jersey (for himself and Mr. Doggett) …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology